SECUKINUMAB

You have access
Secukinumab Immunogenicity over 52 Weeks in Patients with Psoriatic Arthritis and Ankylosing Spondylitis
Atul Deodhar, Dafna D. Gladman, Iain B. McInnes, Sebastian Spindeldreher, Ruvie Martin, Luminita Pricop, Brian Porter, Jorge Safi Jr., Abhijit Shete and Gerard Bruin

The Journal of Rheumatology April 1 2020, 47 (4) 539-547; DOI: https://doi.org/10.3899/jrheum.190116
Open Access
Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study
Arthur Kavanaugh, Iain B. McInnes, Philip J. Mease, Stephen Hall, Hector Chinoy, Alan J. Kivitz, Zailong Wang and Shephard Mpofu

The Journal of Rheumatology September 1 2016, 43 (9) 1713-1717; DOI: https://doi.org/10.3899/jrheum.160275
You have access
Efficacy and Safety of Subcutaneous and Intravenous Loading Dose Regimens of Secukinumab in Patients with Active Rheumatoid Arthritis: Results from a Randomized Phase II Study
Witold Tlustochowicz, Proton Rahman, Bruno Seriolo, Gerhard Krammer, Brian Porter, Albert Widmer and Hanno B. Richards

The Journal of Rheumatology March 1 2016, 43 (3) 495-503; DOI: https://doi.org/10.3899/jrheum.150117
You have access
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova, Jacob A. Aelion, Sang-Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio and Shephard Mpofu

The Journal of Rheumatology March 1 2014, 41 (3) 414-421; DOI: https://doi.org/10.3899/jrheum.130637

Main menu

User menu

Search

SECUKINUMAB

Content

Resources

Subscribers

More